Vanguard Personalized Indexing Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Buy |
38,491
+2,729
| +8% | +$1.22M | 0.19% | 84 |
|
|
2025
Q1 | $17.3M | Buy |
35,762
+4,584
| +15% | +$2.22M | 0.26% | 63 |
|
|
2024
Q4 | $12.6M | Sell |
31,178
-619
| -2% | -$249K | 0.19% | 81 |
|
|
2024
Q3 | $14.8M | Buy |
31,797
+2,340
| +8% | +$1.09M | 0.24% | 66 |
|
|
2024
Q2 | $13.7M | Buy |
29,457
+4,470
| +18% | +$2.08M | 0.26% | 57 |
|
|
2024
Q1 | $10.4M | Buy |
24,987
+909
| +4% | +$380K | 0.22% | 72 |
|
|
2023
Q4 | $9.8M | Sell |
24,078
-1,677
| -7% | -$682K | 0.25% | 61 |
|
|
2023
Q3 | $8.96M | Buy |
25,755
+1,495
| +6% | +$520K | 0.27% | 52 |
|
|
2023
Q2 | $8.54M | Buy |
24,260
+1,884
| +8% | +$663K | 0.26% | 55 |
|
|
2023
Q1 | $7.05M | Buy |
22,376
+1,681
| +8% | +$530K | 0.24% | 69 |
|
|
2022
Q4 | $5.98M | Buy |
20,695
+531
| +3% | +$153K | 0.25% | 65 |
|
|
2022
Q3 | $5.84M | Buy |
20,164
+1,450
| +8% | +$420K | 0.26% | 63 |
|
|
2022
Q2 | $5.27M | Buy |
18,714
+4,809
| +35% | +$1.36M | 0.24% | 70 |
|
|
2022
Q1 | $3.63M | Buy |
13,905
+3,410
| +32% | +$890K | 0.18% | 93 |
|
|
2021
Q4 | $2.31M | Buy |
10,495
+5,739
| +121% | +$1.26M | 0.14% | 134 |
|
|
2021
Q3 | $863K | Buy |
4,756
+2,235
| +89% | +$406K | 0.08% | 269 |
|
|
2021
Q2 | $508K | Sell |
2,521
-1,749
| -41% | -$352K | 0.05% | 471 |
|
|
2021
Q1 | $918K | Buy |
4,270
+1,216
| +40% | +$261K | 0.14% | 164 |
|
|
2020
Q4 | $722K | Sell |
3,054
-50
| -2% | -$11.8K | 0.16% | 146 |
|
|
2020
Q3 | $845K | Buy |
3,104
+1,416
| +84% | +$385K | 0.24% | 89 |
|
|
2020
Q2 | $490K | Buy |
1,688
+471
| +39% | +$137K | 0.22% | 110 |
|
|
2020
Q1 | $290K | Buy |
+1,217
| New | +$290K | 0.17% | 166 |
|